Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis
Modern Rheumatology Case Reports · 07.01.2022 · 6 (1) · 41-46
DOI: 10.1093/mrcr/rxab020 ↗Kurz gefasst
Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, online erschienen am 15.10.2021. Verfasst von Jumpei Temmoku und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Insulin Resistance, Lupus Nephritis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Type B insulin resistance syndrome (TBIR) is a rare autoimmune disease characterised by autoantibodies targeting insulin receptors. TBIR is often complicated by systemic lupus erythematosus (SLE). We describe the case of a 59-year-old Japanese man with TBIR complicated with lupus nephritis (LN), who presented with nephrotic syndrome and severe hypoglycaemia. Treatment with prednisolone (PSL), mycophenolate mofetil (MMF), and tacrolimus (TAC) resulted in improved SLE activity and glucose intolerance with the reduction of anti-insulin receptor autoantibodies. To the best of our knowledge, this is the first reported case of TBIR complicated with LN that was successfully treated using multitarget therapy with PSL, MMF, and TAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Nephrology and Hypertension, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Diabetes, Endocrinology and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Rheumatology, Fukushima Rosai Hospital, Iwaki, Fukushima, Japan.
- Department of Diagnostic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Zitieren
APA
Temmoku, J., Asano, T., Saito, K., Matsumoto, H., Fujita, Y., Furuya-Yashiro, M., Matsuoka, N., Oda, A., Tanabe, H., Sato, S., Shio-Yano, K., Sasajima, T., Kiko, Y., Kobayashi, H., Watanabe, H., Shimabukuro, M., & Migita, K. (2022). Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis. Modern Rheumatology Case Reports, 6(1), 41-46. https://doi.org/10.1093/mrcr/rxab020
Vancouver
Temmoku J, Asano T, Saito K, Matsumoto H, Fujita Y, Furuya-Yashiro M, et al. Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis. Modern Rheumatology Case Reports. 2022;6(1):41-46. doi:10.1093/mrcr/rxab020
BibTeX
@article{Temmoku2022,
author = {Temmoku, Jumpei and Asano, Tomoyuki and Saito, Kenji and Matsumoto, Haruki and Fujita, Yuya and Furuya-Yashiro, Makiko and Matsuoka, Naoki and Oda, Akira and Tanabe, Hayato and Sato, Shuzo and Shio-Yano, Kiori and Sasajima, Tomomi and Kiko, Yuichiro and Kobayashi, Hiroko and Watanabe, Hiroshi and Shimabukuro, Michio and Migita, Kiyoshi},
title = {Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis},
journal = {Modern Rheumatology Case Reports},
year = {2022},
volume = {6},
number = {1},
pages = {41--46},
doi = {10.1093/mrcr/rxab020}
}
EUVIMED